153 related articles for article (PubMed ID: 32945898)
1. Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 × 2 factorial, randomised, crossover study in human individuals.
Hjelholt AJ; Charidemou E; Griffin JL; Pedersen SB; Gudiksen A; Pilegaard H; Jessen N; Møller N; Jørgensen JOL
Diabetologia; 2020 Dec; 63(12):2641-2653. PubMed ID: 32945898
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity.
Nellemann B; Vendelbo MH; Nielsen TS; Bak AM; Høgild M; Pedersen SB; Biensø RS; Pilegaard H; Møller N; Jessen N; Jørgensen JO
Acta Physiol (Oxf); 2014 Feb; 210(2):392-402. PubMed ID: 24148194
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
Nielsen S; Møller N; Christiansen JS; Jørgensen JO
Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
[TBL] [Abstract][Full Text] [Related]
6. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
[TBL] [Abstract][Full Text] [Related]
8. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N
J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132
[TBL] [Abstract][Full Text] [Related]
9. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
Vestergaard ET; Hansen TK; Nielsen S; Moller N; Christiansen JS; Jorgensen JO
Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
[TBL] [Abstract][Full Text] [Related]
10. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
Nørrelund H; Nielsen S; Christiansen JS; Jørgensen JO; Møller N
Eur J Endocrinol; 2004 Jun; 150(6):779-87. PubMed ID: 15191347
[TBL] [Abstract][Full Text] [Related]
11. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
[TBL] [Abstract][Full Text] [Related]
12. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
13. Partial Disruption of Lipolysis Increases Postexercise Insulin Sensitivity in Skeletal Muscle Despite Accumulation of DAG.
Serup AK; Alsted TJ; Jordy AB; Schjerling P; Holm C; Kiens B
Diabetes; 2016 Oct; 65(10):2932-42. PubMed ID: 27489310
[TBL] [Abstract][Full Text] [Related]
14. Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.
Lindegaard B; Ditlevsen S; Plomgaard P; Mittendorfer B; Pedersen BK
Diabetologia; 2013 Sep; 56(9):2034-43. PubMed ID: 23811808
[TBL] [Abstract][Full Text] [Related]
15. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
Nielsen S; Jørgensen JO; Hartmund T; Nørrelund H; Nair KS; Christiansen JS; Møller N
Growth Horm IGF Res; 2002 Dec; 12(6):425-33. PubMed ID: 12423628
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?
Amati F; Dubé JJ; Alvarez-Carnero E; Edreira MM; Chomentowski P; Coen PM; Switzer GE; Bickel PE; Stefanovic-Racic M; Toledo FG; Goodpaster BH
Diabetes; 2011 Oct; 60(10):2588-97. PubMed ID: 21873552
[TBL] [Abstract][Full Text] [Related]
17. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
18. Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle.
Sarabhai T; Koliaki C; Mastrototaro L; Kahl S; Pesta D; Apostolopoulou M; Wolkersdorfer M; Bönner AC; Bobrov P; Markgraf DF; Herder C; Roden M
Diabetologia; 2022 Feb; 65(2):301-314. PubMed ID: 34704121
[TBL] [Abstract][Full Text] [Related]
19. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide.
Dubé JJ; Amati F; Toledo FG; Stefanovic-Racic M; Rossi A; Coen P; Goodpaster BH
Diabetologia; 2011 May; 54(5):1147-56. PubMed ID: 21327867
[TBL] [Abstract][Full Text] [Related]
20. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.
Pontiroli AE; Lanzi R; Monti LD; Pozza G
J Endocrinol Invest; 1990 Jun; 13(6):539-42. PubMed ID: 2258583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
